A carregar...
A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
OBJECTIVE: To evaluate the efficacy and safety of triple fixed-combination bimatoprost 0.01%/brimonidine 0.15%/timolol 0.5% (TFC) versus dual fixed-combination brimonidine 0.2%/timolol 0.5% (DFC) in primary open-angle glaucoma and ocular hypertension. METHODS: Patients with intraocular pressure (IOP...
Na minha lista:
Publicado no: | J Ophthalmol |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Hindawi
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5625812/ https://ncbi.nlm.nih.gov/pubmed/29057117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4586763 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|